Khosla Rachna sold AMGN
August 13, 2026 · Form 4 insider transaction
Khosla Rachna sold 1,252 shares of Amgen Inc. at $416.43 per share, a transaction worth $521.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options.; These shares include 69 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.